FDA Inspection
Abraxis Bioscience, LLCAbraxis Bioscience, LLC – FDA Inspection, Aug 17, 2018
Record Details
This FDA Inspection record concerns Abraxis Bioscience, LLC, with an inspection on August 17, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Jamie L. Dion (Issuing Officer)
- Zachary L. Stamm (FDA Associated Person)
View Company Profile
ID · 4a9fc8a1-2388-43bc-9f2e-6f88696e8fd3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1062643
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(a)Following/documenting laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Abraxis Bioscience, LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| October 6, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 6, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Abraxis Bioscience, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.